JP Morgan Chase
IXHL icon

JP Morgan Chase’s Incannex Healthcare Limited Common Stock IXHL Stock Holding History

JP Morgan Chase’s Portfolio IXHL Stock Details IXHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-825
Closed -$2.51K – 7911
2026
Q1 		$2.51K Buy
+825
New +$6K ﹤0.01% 6977
2024
Q4 		– Hold
0
– -$4 – 7564
2024
Q3 		– Hold
0
– – – 7335
2024
Q2 		– Hold
0
– – – 7233
2024
Q1 		– Hold
0
– – – 7088

Other funds holding IXHL

LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
AdvisorShares Investments
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase's IXHL Position: Q2 2026 in Review

JP Morgan Chase sold out of Incannex Healthcare Limited Common Stock (IXHL) in Q2 2026, closing a stake of 825 shares — an estimated $2.51K sold.

JP Morgan Chase first reported a position in IXHL in Q1 2026 and held it in 1 quarter. The position peaked at $2.51K in Q1 2026. 15 funds tracked by Wall St. Rank hold IXHL as of Q2 2026.

  • JP Morgan Chase reported no remaining Incannex Healthcare Limited Common Stock position as of Q2 2026 after selling out during the quarter.
  • JP Morgan Chase sold 825 Incannex Healthcare Limited Common Stock shares in Q2 2026, an estimated $2.51K.
  • JP Morgan Chase first reported a position in Incannex Healthcare Limited Common Stock in Q1 2026 and held it in 1 quarter.
  • JP Morgan Chase's Incannex Healthcare Limited Common Stock position peaked at $2.51K in Q1 2026.
  • 15 funds tracked by Wall St. Rank held Incannex Healthcare Limited Common Stock as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.